Northwire Canada EditionThursday, July 30, 2026
Northwire
ZAC 0.060 +0.0% ELE 21.18 −1.7% GHRT 0.750 +0.0% AEM 203.13 +0.1% JTWO 0.135 +0.0% EDR 10.63 −2.8% VMXX 0.750 +5.6% K 32.71 −1.5% AGI 40.13 −1.4% VGZ 2.40 +0.8% CAN 0.055 +0.0% NVO 0.055 +0.0% ARIS 19.57 −4.2% IVN 10.59 −0.8% MCI 0.165 +0.0% MTS 0.130 +0.0% ZAC 0.060 +0.0% ELE 21.18 −1.7% GHRT 0.750 +0.0% AEM 203.13 +0.1% JTWO 0.135 +0.0% EDR 10.63 −2.8% VMXX 0.750 +5.6% K 32.71 −1.5% AGI 40.13 −1.4% VGZ 2.40 +0.8% CAN 0.055 +0.0% NVO 0.055 +0.0% ARIS 19.57 −4.2% IVN 10.59 −0.8% MCI 0.165 +0.0% MTS 0.130 +0.0%
Earnings

AYURCANN REPORTS Q1 2026 SALES OF $14,638,697

AYUR · Price

Executive Summary

  • Ayurcann Holdings Corp. reported Q1 2026 interim results, posting CAD 14.64 million in gross revenue and a gross profit of CAD 2.24 million, yielding a 26% gross margin.
  • The company highlighted its position as a top‑3 vape producer in Ontario with a 5% share of the national vape market and a 7% share within Ontario.
  • Over the past six months, Ayurcann launched 30 new SKUs across vapes, pre‑rolls, and concentrates, underscoring accelerated product innovation.

Key Details

  • Revenue: CAD 14,638,697 (Q1 2026) vs. CAD 14,657,485 (Q1 2025).
  • Gross Profit: CAD 2,236,343 (Q1 2026) vs. CAD 3,321,974 (Q1 2025).
  • Gross Margin: 26% in Q1 2026, down from 40% in Q1 2025.
  • Market Position: Ranked among the top three vape producers in Ontario; holds ~5% of Canada’s total vape market and ~7% share in Ontario (source: Hifyre IQTM).
  • Product Expansion: Introduced 30 new SKUs across vapes, pre‑rolls, and concentrates within the last six months.
  • Operational Highlights: Emphasized efficient manufacturing, strong output quality, and on‑time execution.
  • Growth Strategy: Scaling aggressively into high‑demand pre‑rolls and concentrates; expanding distribution through licensed Canadian retail stores.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Ayurcann Holdings Corp.